Skip to main content

29 June 2022

Last updated: Saturday 25 June 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Will CRISPR be safe enough for the clinic?

Sunday 23 September 2018

Interviewee/Contributor

Jonathan Moore

How genome editing is impacting cell therapy

Tuesday 1 May 2018

Interviewee/Contributor

Jonathan Moore

Organisation

Horizon Discovery Group Plc

Organisations

Biotec Pharmacon ASA
The Human Brain Project and EBRAINS
Aduro Biotech Inc
Simmons & Simmons LLP
MedImmune
Consultant and MedNous Editorial Board Member
Storm Therapeutics Ltd
Aravis Venture
Novo Seeds
Pfizer Regenerative Medicine

Interviewees and Contributers

Arthur Oubrie
Christina Curtis
Alfred Scheidegger
Frank Carr
Graeme Martin
Jonathan D Moore
Morten Grunnet
Marisa Papaluca-Amati
Steven Pearson
Bernard Huber and Paul Higham

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Colin McCracken becomes CEO of Evonetix

Saturday 25 June 2022

Valo appoints Hemanshu Shah as CBO

Saturday 25 June 2022

David Gilman to head business strategy at ADC Therapeutics

Saturday 25 June 2022

CureVac appoints new chief development officer

Saturday 25 June 2022

Steffen Thirstrup becomes CMO at the EMA

Saturday 25 June 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form